Daily Intel Knowledge Base
Research pages, comparison hubs and operating guides.
A structured library for Daily Intel methodology, pricing, trust, VSL research, ad repositories, blackhat and whitehat context, niche intelligence and buyer decisions.
Indexed structure
- Core entries
- 2866+
- Collections
- 107
- Niche pages
- 790
- Glossary terms
- 57
Niche
GLP-1 Affiliate Marketing Intelligence
Daily Intel Service tracks GLP-1, semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro, and compounded pharmacy demand through active-scaling ads, VSLs
Niche
Nutra Niches
Directory of Daily Intel Service niche intelligence pages for GLP-1, weight loss, blood sugar, prostate, joint pain, vision, sleep, hair, dental, gut
Niche
'Balance' and 'Support' Do Not Save Thyroid Copy
FDA quoted 'To balance thyroid gland functioning especially in case of Hypothyroidism' as a drug claim. The hedge verb came along with the citation.
Niche
'Better Than the Injection' Is a Disease Claim
The replace-your-medication angle is the most common line in joint, vein and sleep creative.
Showing 327 pages
GLP-1 Affiliate Marketing Intelligence
Daily Intel Service tracks GLP-1, semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro, and compounded pharmacy demand through active-scaling ads, VSLs
Nutra Niches
Directory of Daily Intel Service niche intelligence pages for GLP-1, weight loss, blood sugar, prostate, joint pain, vision, sleep, hair, dental, gut
'Balance' and 'Support' Do Not Save Thyroid Copy
FDA quoted 'To balance thyroid gland functioning especially in case of Hypothyroidism' as a drug claim. The hedge verb came along with the citation.
'Better Than the Injection' Is a Disease Claim
The replace-your-medication angle is the most common line in joint, vein and sleep creative.
'Lowers Cholesterol, However Qualified' Is a Drug Claim
FDA wrote the word 'however qualified' into the rule, then swept in 'promotes cholesterol clearance' too. There is no hedge that survives.
'Maintain Normal Urine Flow' Reads as Treatment
The support-and-maintain hedge that carries every other nutra vertical collapses in prostate, and FDA published the exact reasoning for why.
'Nerve Support' Did Not Save NeuropAWAY
VasoCorp softened every line to support language and still drew a warning letter in July 2026.
'Not for Human Consumption' Did Not Save SARMs
The research-compound disclaimer is the standard defense in hormone-adjacent offers.
'Occasional' Is the Word Holding Up Energy Offers
FDA wrote out an acceptable fatigue claim and said in the same breath that chronic fatigue and daytime drowsiness point at named diseases.
'Potency' Is the Word That Turns an Ad Into a Drug
FDA wrote out, sentence by sentence, which male sexual-performance phrasings are structure/function claims and which are disease claims.
'Promotes Low Blood Pressure' Is Already a Drug Claim
FDA names hypertension inside the definition of disease itself, and the 2000 preamble kills the soft verb: 'promotes' fails exactly like 'lowers'.
'Ringing in the Ears' Is Cited Text, Not a Workaround
Two FDA letters quote the vernacular phrasing back at the seller. The subparagraph that governs says lay terminology counts, so paraphrasing tinnitus into
'Supports Metabolism' Is a Wrapper, Not a Shield
The phrase is lawful under 21 CFR 101.93(f). What converts it is the obesity imagery, diabetes vocabulary or symptom list around it.
"Hepata-" Anything: The Name FDA Flagged in 2000
The clearest naming rule in the whole rulemaking is a liver example — and it comes with the one thing advertisers rarely get from FDA: a stated way
"Occasional" Is the Word Holding Heartburn Copy Up
FDA drew the heartburn line on a single adjective: "occasional" is a structure/function claim, "recurrent" or "persistent" is a disease claim reading as
$3.5M in Refunds at $33 a Check: The Redress Math
12 in one weight-loss supplement case. Redress scales with order count, not with margin.
A Bulging-Leg Before/After Is the Disease Claim
Veins are a visual condition, which is why the creative carries the exposure. FDA treats a picture of abnormal tissue as an implied disease claim on its
A Cavity Claim Makes It an Unapproved OTC Drug
Teeth and gums carry the lowest ceiling in nutra for a structural reason: cavity prevention is an OTC drug category whose only permitted actives
A Facebook Like Became an Endorsement: BergaMet
FDA wrote 'You also endorsed the following responses to your post by liking them' — then quoted a comment reading 'this is the answer not a statin!'
A Heart Icon Can Be the Disease Claim by Itself
FDA treats the heart symbol and a healthy EKG tracing as implied heart-disease claims.
A Pre-Lander Need Not Sell to Become the Evidence
FDA quoted a pure editorial page — 'How Stress Affects the Body' — with no product mention, because a different page tied the products to the same issue.
A Probiotic Brand Was Sunk by Its Own Bibliography
FDA turned Evivo into an unapproved drug and an unlicensed biologic on the strength of two article titles linked from the website.
Absentmindedness Is Allowed. Memory Loss Is Not.
FDA drew the memory line in one paragraph: age-related mild memory problems are not a disease, and 'improves absentmindedness' passes because
Anti-Aging's Floor: Alzheimer's, Osteoporosis, Glaucoma
The same FDA rule that freed wrinkle claims lists the diseases of aging that stay off-limits.
Page 1 of 14